Navigation Links
Medication Plus Behavior Changes Help Obese Adolescents Lose Weight

The weight loss medication sibutramine, when combined with behavior therapy, allowed hundreds of very obese adolescents to lose an average of 14 pounds over a year//, according to a multicenter study in the July 18 Annals of Internal Medicine. Adolescents in the study who received a placebo (a sugar pill) gained four pounds over the year.

In addition to reductions in body mass index and weight, the treated adolescents had improvements in disease risk factors associated with obesity. They had lower levels of triglycerides and higher levels of high-density lipoprotein cholesterol, which are related to heart disease, and lower levels of insulin, a risk factor for diabetes. The only significant side effect was tachycardia, or rapid heart beat.

Although sibutramine, sold under the brand name Meridia, is currently used in adults with obesity, “this is the first large multicenter trial of sibutramine for obese adolescents,” said study leader Robert I. Berkowitz, M.D., chief of Child and Adolescent Psychiatry at The Children’s Hospital of Philadelphia. “In fact, there have been few trials evaluating any obesity drugs in adolescents.”

Behavior therapy alone, said Dr. Berkowitz, usually provides only modest weight loss in adolescents, and thus medication may provide an additional treatment option for this age group.

The study enrolled 498 severely obese adolescents, aged 12 to 16, in 33 outpatient clinics throughout the United States from 2000 to 2002. The patients were randomized into two double-blinded groups, one receiving sibutramine and one receiving a placebo, while both groups received behavior therapy.

Each treatment center had its own behavior therapy program, with flexible modification approaches that included self-monitoring of eating habits and physical activity, stress management, stimulus control, problem solving and social support. Counselors encouraged patients to increase their physical activity and
'"/>




Page: 1 2 3

Related medicine news :

1. What happens when Medications go wrong?
2. Medications to Prevent Relapse to Cocaine Use
3. More Elderly Take Inappropriate and Harmful Medications
4. Medications for depression
5. Medications linked to xerostomia and caries
6. Medication recuperates fat distribution in diabetes
7. Pharmacist’s Role in Medication Error
8. The Downside of Asthma Medication
9. Reducing Medication Errors
10. Oral Medication Effective In Combating Eye Infection
11. New Medication May Decrease The Frequency Of Angina Attacks
Post Your Comments:
Other Medicine News:Health News:Senators Lugar, Dodd, Boxer and Representatives Lee and McCollum Receive GAC Children's Champion Award 2Health News:Study shows surgery provides good long-term outcomes for patients with gastrointestinal cancers 2Health News:Medtronic, Inc. and Medtronic Sofamor Danek USA, Inc. Sued for Product Liability and Promoting the Off-Label Use of Infuse(R) Bone Graft Product, According to Page Perry, LLC 2Health News:Environmental Tectonics Corporation Announces Third Quarter and Year To Date Fiscal 2009 Results 2Health News:Environmental Tectonics Corporation Announces Third Quarter and Year To Date Fiscal 2009 Results 3Health News:Environmental Tectonics Corporation Announces Third Quarter and Year To Date Fiscal 2009 Results 4Health News:Environmental Tectonics Corporation Announces Third Quarter and Year To Date Fiscal 2009 Results 5Health News:Environmental Tectonics Corporation Announces Third Quarter and Year To Date Fiscal 2009 Results 6Health News:Environmental Tectonics Corporation Announces Third Quarter and Year To Date Fiscal 2009 Results 7Health News:Environmental Tectonics Corporation Announces Third Quarter and Year To Date Fiscal 2009 Results 8Health News:Environmental Tectonics Corporation Announces Third Quarter and Year To Date Fiscal 2009 Results 9Health News:Environmental Tectonics Corporation Announces Third Quarter and Year To Date Fiscal 2009 Results 10Health News:Most support Alzheimer's research based on family consent 2Health News:Most support Alzheimer's research based on family consent 3Health News:Physical activity, mood and serious mental illness 2
Breaking Medicine Technology:SRI International Receives National Institutes of Health Grants to Develop Improved Tomographic Imaging Technology 2SRI International Receives National Institutes of Health Grants to Develop Improved Tomographic Imaging Technology 3NOVAVAX Announces Closing of Public Offering of 6,800,000 Shares of Common Stock 2Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 2Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 3Living in U S May Raise Hispanics Cancer Risk 53835 1Living in U S May Raise Hispanics Cancer Risk 53835 2Living in U S May Raise Hispanics Cancer Risk 53835 3Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 1Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 2Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 3Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 4Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 5Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 6Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 7Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 8Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 9Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 10Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 11Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 12Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 13Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 14Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 15Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 16Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 17Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 18Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 19Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 20Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 21Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 22Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 23Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 24Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 25Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 26Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 27Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 28Genomic Health to Present at Canaccord Adams 29th Annual Global Growth Conference 53829 1